TAILIEUCHUNG - The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma

Melanoma-intrinsic activated β-catenin pathway, the product of the catenin beta 1 (CTNNB1) gene, has been associated with low/absent tumor-infiltrating lymphocytes, accelerated tumor growth, metastases development, and resistance to anti-PD-L1/anti-CTLA-4 agents in mouse melanoma models. | Karachaliou et al. BMC Cancer 2022 22 38 https s12885-021-08908-z RESEARCH Open Access The clinical significance of adenomatous polyposis coli APC and catenin Beta 1 CTNNB1 genetic aberrations in patients with melanoma Georgia Sofia Karachaliou1 Rached Alkallas2 Sarah B. Carroll1 Chongshan Caressi3 Danny Zakria4 Nirali M. Patel5 6 Dimitri G. Trembath5 Jennifer A. Ezzell7 Guillaume J. Pegna1 Paul B. Googe8 Jonathan P. Galeotti5 Fatih Ayvali1 Frances A. Collichio1 6 Carrie B. Lee1 6 David W. Ollila6 9 Margaret L. Gulley5 6 Douglas B. Johnson4 Kevin B. Kim3 Ian R. Watson2 and Stergios J. Moschos1 6 Abstract Background Melanoma-intrinsic activated β-catenin pathway the product of the catenin beta 1 CTNNB1 gene has been associated with low absent tumor-infiltrating lymphocytes accelerated tumor growth metastases development and resistance to anti-PD-L1 anti-CTLA-4 agents in mouse melanoma models. Little is known about the association between the adenomatous polyposis coli APC and CTNNB1 gene mutations in stage IV melanoma with immunotherapy response and overall survival OS . Methods We examined the prognostic significance of somatic APC CTNNB1 mutations in the Cancer Genome Atlas Project for Skin Cutaneous Melanoma TCGA-SKCM database. We assessed APC CTNNB1 mutations as predictors of response to immunotherapies in a clinicopathologically annotated metastatic patient cohort from three US melanoma centers. Correspondence moschos@ 1 Department of Medicine The University of North Carolina at Chapel Chapel Hill Chapel Hill NC USA 6 Lineberger Comprehensive Cancer Center The University of North Carolina at Chapel Hill Chapel Hill NC USA Full list of author information is available at the end of the article The Author s . 2022 Open Access This article is licensed under a Creative Commons Attribution International License which permits use sharing adaptation distribution and reproduction in any medium or format as long as you give appropriate .

• Y khoa - Dược
• BMC Cancer
• Central nervous system neoplasms
• Genetic markers
• Melanoma intrinsic activated β catenin pathway
• Absent tumor infiltrating lymphocytes
• Anti CTLA 4 agents
• Cancer patient pathways
• Colorectal cancer
• Lung cancer
• Breast cancer
• Prostate cancer
• Ovarian cancer
• Cancer detection
• Ovarian cancer symptoms
• Ovarian cancer signs
• Ovarian cancer tests
• Cancer biomarkers
• Pediatric cancer
• Familial cancer predisposition
• Hereditary cancer syndrome
• Genetic cancer susceptibility
• Advanced cancer
• Biliary tract cancer
• Multimodal intervention
• Pancreatic cancer
• Physical activity
• Breast cancer screening
• Familial breast cancer
• Young breast cancer survivors
• High risk relatives
• Randomized trial
• Childhood cancer
• Childhood cancer survivor
• Thyroid cancer screening
• Secondary cancer
• Cancer screening
• Community awareness
• Cancer education
• Cervical cancer
• Prior cancer
• Cancer survivors
• Cancer registry
• Second cancer
• Surgical oncology
• Cancer imaging
• Radiation oncologists
• Medical oncologists
• Oesophagogastric cancer
• Liver cancer
• Hepatobiliary cancer
• Multidisciplinary rehabilitation
• EGFR mutation
• Family history of cancer
• Inherited susceptibility
• Cancer predisposition genes
• Lung cancer aetiology
• Cancer stem cells
• Oct4 overexpressing lung cancer
• Human lung cancer xenograft model
• Disease free survivals
• Cancer hallmarks
• Cancer genesis
• Defiant disease
• Mutational signature
• Cancer diagnosis
• Cancer genomics
• Molecular medicine
• Whole genome sequencing
• Cancer susceptibility gene
• Breast cancer prognosis
• Next generation sequencing
• Quality of care
• Quality indicators
• Shifting cancer care
• German cancer society
• Colorectal cancer screening
• Stomach cancer screening
• Lung cancer survivor
• Physician recommendation
• Total number of lymph nodes
• Lymph node ratio
• Left colon cancer
• Right colon cancer
• Overall survival
• Cumulative incidence
• Esophageal cancer
• Head and neck cancer
• Metachronous cancer
• Young onset
• Reproductive cancer
• Risk factor
• Early detection of cancer
• Gastric cancer incidence
• Population based specialized registry
• Gastric cancer survival
• Gastric cancer clinical characteristics
• Gastric cancer pathological characteristics
• Lung Cancer Screening
• Racial disparities
• Lung Cancer diagnosis
• Screening adherence
• Second primary colorectal cancer
• Standardized incidence ratio
• Left sided colon cancer
• Right sided colon cancer
• Quality of cancer care
• Population based study